Eli Lilly has turned its numbers around and become the world’s most valuable pharma company, thanks to its type 2 diabetes and off-label use obesity…

The latest pharma industry news from Germany, including Lilly's new German plant; Bayer's aborted anti-clotting drug trial and legal worries;…

Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish…

The latest news from UK healthcare and life sciences, including the safety review of Novo Nordisk's GLP-1 receptor agonists; VaxEquity's grant to…

Smart manufacturing has become a key component of today’s industrial evolution and unlocked unprecedented efficiencies and quality enhancements.…

Eli Lilly recently revealed more than promising clinical trial results for its Alzheimer’s candidate, donanemab, showing that the drug slows…

Thanks to its world-renowned networks of medical and academic institutions, the long-standing presence of Big Pharma, and a favourable regulatory…

Life sciences have been steadily losing ground in the UK with a significant drop in global R&D investments and a decreasing number of patients…

Big Pharma has been raging against the US’s Inflation Reduction Act (IRA) ever since it was passed last year. Merck (MSD global) has recently taken…

Despite the thriving life sciences ecosystem that has made Belgium one of the top European destinations for clinical trials, the country continues to…

Eli Lilly Belgium's Frederic Clais discusses the potential impact of upcoming reform of the country's access and reimbursement system, the country's…

After considerable government pressure to reduce insulin costs in the US, Eli Lilly recently slashed its prices by as much as 70 percent, followed by…